Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Oramed Pharm Inc

CUSIP: 68403P953 | 6 institutional holders

Quarters

Q2 2026 Q1 2026 Q2 2025 Q1 2025 Q4 2024

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile